Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 10—October 2010
Research

Oral Fluid Testing during 10 Years of Rubella Elimination, England and Wales

Gayatri Manikkavasagan, Antoaneta Bukasa, Kevin E. Brown, Bernard J. Cohen, and Mary E. RamsayComments to Author 
Author affiliations: Author affiliation: Health Protection Agency Centre for Infections, London, UK

Main Article

Table 3

Regional variation in rubella reports by oral (crevicular) fluid testing and confirmed cases from oral fluid and serum, England and Wales, 1999–2008

Region No. reported cases Incidence of reported cases* No. oral fluid tests (% total reports) No. cases confirmed by oral fluid testing No. cases confirmed by serum testing Annual incidence of confirmed cases*
Confirmed by oral fluid testing† Confirmed by serum testing Total
East Midlands 1,336 319 1,065 (80) 3 9 0.09 0.21 0.29
Eastern 1,212 224 1,232 (102)‡ 44 32 0.80 0.59 1.41
London 1,653 226 1,452 (88) 32 67 0.67 0.92 1.35
North East 840 331 574 (68) 0 12 0.00 0.47 0.47
North West 1,662 245 1,505 (91) 12 13 0.25 0.19 0.37
South East 2,363 295 2,350 (99) 18 48 0.34 0.60 0.82
South West 1,109 224 857 (77) 13 40 0.31 0.81 1.07
West Midlands 1,235 234 821 (66) 12 10 0.33 0.19 0.42
Wales 639 220 518 (81) 1 10 0.02 0.34 0.38
Yorkshire and Humberside 1,903 382 1,260 (66) 7 22 0.20 0.44 0.58
Not specified
75
 1
 0
Total 13,952 266 11,709 (84) 143 263 0.31 0.50 0.77

*Incidence per 1 million population. Annual incidence calculated by using 2001 census population figures.
†Adjusted for proportion of cases tested.
‡Several oral fluid tests were conducted for cases that were not formally reported during university outbreaks in 3 regions in 1999, including the South West, Eastern, and North West regions (17).

Main Article

References
  1. Health Protection Agency. General information on rubella (German measles). London: The Agency; 2009. 2–2-0009.
  2. Ramsay  ME, Brugha  R, Brown  DW, Cohen  BJ, Miller  E. Salivary diagnosis of rubella: a study of notified cases in the United Kingdom, 1991–4. Epidemiol Infect. 1998;120:315–9. DOIPubMedGoogle Scholar
  3. Ramsay  M, Gay  N, Miller  E, Rush  M, White  J, Morgan-Capner  P, The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev. 1994;4:R141–6.PubMedGoogle Scholar
  4. Regional World Health Organization Office for Europe. Strategic plan for measles and congenital rubella infection in the WHO European Region. Copenhagen: The Organization; 2003.
  5. World Health Organization Vaccine Assessment and Monitoring team DoVaB. WHO-recommended standards for surveillance of selected vaccine preventable diseases. Geneva: The Organization; 2003.
  6. Malamud  D. Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med. 1997;102:9–14. DOIPubMedGoogle Scholar
  7. Mortimer  PP, Parry  JV. The use of saliva for viral diagnosis and screening. Epidemiol Infect. 1988;101:197–201. DOIPubMedGoogle Scholar
  8. Parry  JV, Mortimer  PP. Non-invasive virological diagnosis: are saliva and urine specimens adequate substitutes for blood? Review of Medical Microbiology. 1991;1:73–8.
  9. Parry  JV. Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance. Ann N Y Acad Sci. 1993;694:216–33. DOIPubMedGoogle Scholar
  10. Nokes  DJ, Enquselassie  F, Vyse  A, Nigatu  W, Cutts  FT, Brown  DW. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Trans R Soc Trop Med Hyg. 1998;92:679–85. DOIPubMedGoogle Scholar
  11. Eckstein  MB, Brown  DW, Foster  A, Richards  AF, Gilbert  CE, Vijayalakshmi  P. Congenital rubella in south India: diagnosis using saliva from infants with cataract. BMJ. 1996;312:161.PubMedGoogle Scholar
  12. Nokes  DJ, Enquselassie  F, Nigatu  W, Vyse  AJ, Cohen  BJ, Brown  DW, Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ. 2001;79:588–95.PubMedGoogle Scholar
  13. Jin  L, Vyse  A, Brown  DW. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ. 2002;80:76–7.PubMedGoogle Scholar
  14. Vyse  AJ, Jin  L. An RT-PCR assay using oral fluid samples to detect rubella virus genome for epidemiological surveillance. Mol Cell Probes. 2002;16:93–7. DOIPubMedGoogle Scholar
  15. Abernathy  E, Cabezas  C, Sun  H, Zheng  Q, Chen  MH, Castillo-Solorzano  C, Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid. J Clin Microbiol. 2009;47:182–8. DOIPubMedGoogle Scholar
  16. Miller  E, Waight  P, Gay  N, Ramsay  M, Vurdien  J, Morgan-Capner  P, The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev. 1997;7:R26–32.PubMedGoogle Scholar
  17. Rubella in university students. Commun Dis Rep CDR Wkly. 1999; 9:113, 116.
  18. Ramsay  ME, Jin  L, White  J, Litton  P, Cohen  B, Brown  D. The elimination of indigenous measles transmission in England and Wales. J Infect Dis. 2003;187(Suppl 1):S198–207. DOIPubMedGoogle Scholar
  19. Savage  E, Ramsay  M, White  J, Beard  S, Lawson  H, Hunjan  R, Mumps outbreaks across England and Wales in 2004: observational study. BMJ. 2005;330:1119–20. DOIPubMedGoogle Scholar
  20. Perry  KR, Brown  DW, Parry  JV, Panday  S, Pipkin  C, Richards  A. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol. 1993;40:235–40. DOIPubMedGoogle Scholar
  21. Vyse  AJ, Brown  DW, Cohen  BJ, Samuel  R, Nokes  DJ. Detection of rubella virus–specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate. J Clin Microbiol. 1999;37:391–5.PubMedGoogle Scholar
  22. Vijaylakshmi  P, Muthukkaruppan  VR, Rajasundari  A, Korukluoglu  G, Nigatu  W, Warrener  LA, Evaluation of a commercial rubella IgM assay for use on oral fluid samples for diagnosis and surveillance of congenital rubella syndrome and postnatal rubella. J Clin Virol. 2006;37:265–8. DOIPubMedGoogle Scholar
  23. Thomas  HI, Morgan-Capner  P, Enders  G, O’Shea  S, Caldicott  D, Best  JM. Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods. 1992;39:149–55. DOIPubMedGoogle Scholar
  24. Vyse  AJ, Gay  NJ, White  JM, Ramsay  ME, Brown  DW, Cohen  BJ, Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev. 2002;24:125–36. DOIPubMedGoogle Scholar
  25. Tait  DR, Ward  KN, Brown  DW, Miller  E. Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella. BMJ. 1996;312:101–2.PubMedGoogle Scholar
  26. Hogan  PA. Viral exanthems in childhood. Australas J Dermatol. 1996;37(Suppl 1):S14–6. DOIPubMedGoogle Scholar
  27. de Oliveira  SA, Camacho  LA, Medeiros Pereira  AC, Bulhoes  MM, Aguas  AF, Siqueira  MM. Performance of rubella suspect case definition: implications for surveillance. Rev Saude Publica. 2006;40:450–6. DOIPubMedGoogle Scholar
  28. Recommendations from an ad hoc meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance. MMWR Morb Mortal Wkly Rep. 2008;57:657–60.PubMedGoogle Scholar
  29. Centers for Disease Control and Prevention. Mumps epidemic—United Kingdom, 2004–2005. MMWR Morb Mortal Wkly Rep. 2006;55:173–5.PubMedGoogle Scholar
  30. United Kingdom Department of Health. The MMR catch-up programme. 2008 Aug 7 [cited 2010 Jul 7]. http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Professionalletters/Chiefmedicalofficerletters/DH_086837
  31. Regional World Health Organization Office for Europe. Surveillance guidelines for measles, rubella and congenital rubella syndrome in the WHO European Region. Copenhagen: The Organization; 2009.
  32. EUVAC. Rubella surveillance report 2000–2007 [cited 2010 Jul 7]. http://www.euvac.net/graphics/euvac/pdf/rubella_report.pdf
  33. Vyse  AJ, Gay  NJ, Hesketh  LM, Pebody  R, Morgan-Capner  P, Miller  E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect. 2006;134:1303–12. DOIPubMedGoogle Scholar

Main Article

Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external